secwatch.observer — SEC 8-K summary
======================================

Issuer:     IMMUNIC, INC. (IMUX)
CIK:        0001280776
Form:       8-K
Filed at:   2023-06-30T23:59:59+00:00
Accession:  0001193805-23-000931
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Immunic shareholders elect Rudick and Törnsén, ratify auditor, approve share plan amendment
--------------------------------------------------------------------------------

- Dr. Richard Rudick and Maria Törnsén elected to three-year terms with ~19.9M votes for each; ~5.65M broker non-votes.
- Baker Tilly Virchow Krause, LLP ratified as independent auditor for 2023; 25.5M for, 75K against, 71K abstain.
- Amendments to 2019 Omnibus Plan approved: shares authorized increased by 4,440,000 to 10,348,871; evergreen provision removed.
- Quorum of 25,616,356 shares represented at meeting out of 44,403,838 entitled to vote.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1280776/000119380523000931/0001193805-23-000931-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1280776/000119380523000931/e618747_8k-immunic.htm
  HTML page:      https://secwatch.observer/filing/0001193805-23-000931

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer